Asymptomatic 70% ICA Stenosis in a Patient with Contralateral Occlusion
A 68-year-old right-handed man with hypertension and a 30 pack-year smoking history presents after a single episode of transient right-hand weakness lasting 8 minutes, now fully resolved (NIHSS 0). Carotid duplex shows a left ICA peak systolic velocity of 285 cm/s, end-diastolic velocity of 110 cm/s, and a broad spectral fill-in consistent with a hemodynamically significant stenosis; the right ICA is completely occluded with a string sign on color flow. The left ICA stenosis is estimated at 70-79% by velocity criteria. MRI shows no acute infarct and no cortical watershed pattern. The patient is on aspirin 81 mg and atorvastatin 80 mg. Blood pressure is 138/82. The vascular surgeon is recommending left carotid endarterectomy but asks you to comment on perioperative risk given the contralateral occlusion.
1. How does the contralateral ICA occlusion change your interpretation of the left-sided velocity findings and your confidence in the 70-79% estimate?
Read the worked answer
Contralateral occlusion is a recognized cause of velocity overestimation in the patent ICA. With the right ICA occluded, the left ICA carries a larger share of total cerebral inflow, so PSV and EDV rise without a proportional increase in anatomic narrowing. A PSV of 285 cm/s in this setting cannot be read against standard velocity thresholds as if the contralateral vessel were normal.
Practical adjustments:
- Do not treat the velocity number as the sole severity marker. Use morphology and secondary parameters: spectral broadening, post-stenotic turbulence, and the ICA/CCA ratio (less flow-dependent than absolute PSV).
- Confirm with a second modality. CTA or MRA gives an anatomic percentage; if there is discordance, the higher-grade anatomic study plus the clinical picture should drive the decision.
- The 8-minute right-hand episode is a left-hemispheric TIA and is the strongest single piece of evidence that this lesion is symptomatic - severity estimation matters less than the fact that it is the culprit.
Conclusion: the stenosis is at minimum severe enough to be symptomatic, but the exact 70 vs 80% band is not reliably established by duplex alone here. Recommend confirmatory CTA/MRA before committing to a surgical risk discussion that hinges on a precise percentage.
2. The surgeon asks whether contralateral occlusion is a contraindication to CEA. How do you frame the perioperative risk and the alternatives?
Read the worked answer
Contralateral occlusion is not an absolute contraindication to CEA, but it is a marker of increased perioperative risk - chiefly hemodynamic stroke during cross-clamping and hyperperfusion syndrome after reperfusion, because the left hemisphere has no contralateral collateral reserve.
Framing for the surgeon:
- The 30-day stroke/death risk is higher than in patients with a patent contralateral ICA. The decision rule is that benefit requires the perioperative risk to be lower than the risk of the untreated symptomatic lesion (roughly 20-25% at 2 years for severe symptomatic stenosis). If the estimated perioperative risk approaches that, surgery loses its margin.
- Mitigation matters: selective shunting or routine shunting, EEG or NIRS neuromonitoring during clamp, and strict postoperative blood pressure control to prevent hyperperfusion.
- CAS is an alternative but carries its own embolic risk and is generally not favored in patients with unfavorable arch anatomy; it does not eliminate the hyperperfusion concern.
- Best medical therapy alone (dual antiplatelet for a limited period, high-intensity statin, BP and smoking control) is a legitimate comparator, especially if the perioperative risk estimate is high.
The judgment call: this is a symptomatic severe stenosis with a high-risk substrate, so intervention is reasonable, but the risk conversation must be explicit and the mode (CEA with shunt vs CAS vs medical) should be individualized rather than defaulted.